• Users Online: 159
  • Print this page
  • Email this page
Year : 2020  |  Volume : 4  |  Issue : 1  |  Page : 84-86

Schizophrenia with segawa syndrome: A therapeutic challenge

1 Department of Psychiatry, BJGMC and Sassoon General Hospital, Pune, Maharashtra, India
2 Department of Psychiatry, PCMC's Postgraduate Institute, Yashwantrao Chavan Memorial Hospital, Pune, Maharashtra, India

Correspondence Address:
Dr. Disha Devang Parikh
Department of Psychiatry, BJGMC and Sassoon General Hospital, Pune, Maharashtra
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/aip.aip_41_19

Rights and Permissions

Segawa syndrome is inherited dystonia characterized by gait disturbance and dystonia. The patients benefit from the treatment with levodopa. Although behavioral changes are known to be associated with this condition, there is limited literature on psychosis. Levodopa has been known to induce psychosis, while antipsychotics can exacerbate dystonia. Hence, a calculated approach is required for adequate management of both the conditions. This case report describes a 32-year-old male with dystonia for 20 years and psychotic symptoms for 16 years. He was on levodopa 250 mg BD for 5 years but was taking three times the prescribed dose for 3 years along with erratic antipsychotic treatment. He was successfully treated with levodopa 250 mg BD to control his dystonia symptoms and clozapine 200 mg for psychotic symptoms. Schizophrenia with Segawa syndrome is a rare presentation. The case was challenging owing to the complexity of presenting symptoms as well as the treatment.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded32    
    Comments [Add]    

Recommend this journal